Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Foundation Medicine received early financing of $7.0M on 2010-04-15.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $7M | 04/2010 |
| Series A | $33.5M | 10/2011 |
| Series B | $42.5M | 09/2012 |
| Series B | $13.5M | 01/2013 |
| Investors | Security type |
|---|---|
| Third Rock Ventures | Series A |
| Kleiner Perkins | Series A |
| GV | Series A |
| Redmile Group | Series B |
| Third Rock Ventures | Series B |
| Roche Venture Fund | Series B |
| Kleiner Perkins | Series B |
| GV | Series B |
| Deerfield Capital Management | Series B |
| Casdin Capital | Series B |
| Evan Jones | Series B |
| Bill Gates | Series B |
Foundation Medicine's top competitor, Merck, earned an annual revenue of $64.2B.
Foundation Medicine's smallest competitor is Caris Life Sciences with revenue of $13.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 27 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 608 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Quidel | $71,489 | $1.7B | 1,500 | - |
| Caris Life Sciences | $67,870 | $13.0M | 843 | 149 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Cubist Pharmaceuticals | $91,725 | $926.4M | 873 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,852 |
| Myriad Genetics | $59,486 | $183.5M | 2,600 | 180 |
Zippia gives an in-depth look into the details of Foundation Medicine, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Foundation Medicine. The employee data is based on information from people who have self-reported their past or current employments at Foundation Medicine. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Foundation Medicine. The data presented on this page does not represent the view of Foundation Medicine and its employees or that of Zippia.
Foundation Medicine may also be known as or be related to Foundation Medicine, Foundation Medicine Inc, Foundation Medicine Inc. and Foundation Medicine, Inc.